Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Algernon Pharmaceuticals (AGNPF)
OTHER OTC:AGNPF
Holding AGNPF?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 08, 2024 | James Kinley Chief Financial Officer | xxxxxxxxxxxxx | C$27000 |
| Aug 03, 2024 | Christopher Joseph Moreau Chief Executive Officer | xxxxxxxxxxxxx | C$50760 |
| Jun 28, 2024 | Christopher Joseph Moreau Chief Executive Officer | xxxxxxxxxxxxx | C$2145 |
| Jun 07, 2024 | Christopher Joseph Moreau Chief Executive Officer | xxxxxxxxxxxxx | C$2030 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Algernon Pharmaceuticals (AGNPF)?
Currently, no data Available
What percentage of Algernon Pharmaceuticals (AGNPF) stock is held by institutional investors?
Currently, no data Available
What percentage of Algernon Pharmaceuticals (AGNPF) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Algernon Pharmaceuticals (AGNPF)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.